Effect of Liraglutide on Arterial Inflammation Assessed as [(18)F]FDG Uptake in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial

The mechanism behind the cardiovascular protection observed with human GLP-1 RA (glucagon-like peptide-1 receptor agonists) in type 2 diabetes is unknown. We hypothesized that treatment with the GLP-1 RA liraglutide had a positive effect on vascular inflammation. METHODS: LIRAFLAME (Effect of liragl...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Circ Cardiovasc Imaging
Main Authors: Ripa, Rasmus S., Zobel, Emilie H., von Scholten, Bernt J., Jensen, Jacob K., Binderup, Tina, Diaz, Lars J., Curovic, Viktor R., Hansen, Tine W., Rossing, Peter, Kjaer, Andreas
Formato: Artigo
Idioma:Inglês
Publicado: Lippincott Williams & Wilkins 2021
Assuntos:
Original Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8300846/
https://ncbi.nlm.nih.gov/pubmed/34187185
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCIMAGING.120.012174
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares